Summary
The effects of calcitonin gene-related peptide (CGRP) on canine cerebral arteries and on vertebral blood flow were investigated in-vivo and in-vitro and the findings compared with the effects of vasoactive intestinal peptide (VIP) and substance P. Administration of CGRP into the vertebral artery caused a dose-dependent and long-lasting increase in blood flow. The in-vivo vasodilatory effects of substance P and VIP were short-lasting. CGRP (0.1 to 100 nmol/l) elicited a concentration-dependent relaxation of the isolated middle cerebral and basilar arteries when the tissues were precontracted by exposure to prostaglandin F2α (PGF2α). This effect was not antagonized by propranolol, atropine, tetrodotoxin, (N-Ac-Tyr1, D-Phe2)-growth hormone-releasing factor(1–29)-NH2 or (D-Pro2, D-Trp7,9) substance P. CGRP also reduced concentration-dependently the contraction of cerebral arteries induced by KCl or 9,11-epithio-11,12-metano-thromboxane A2 (STXA2). Mechanical removal of the endothelium did not abolish the vasodilatory response to CGRP. In PGF2α-contracted canine cerebral arteries, VIP (0.1 to 100 nmol/l) was less potent a vasodilator than CGRP. At low concentrations (0.01 to 1 nmol/l) substance P elicited a rapid and short-lasting relaxation, and in the absence of endothelium this relaxation disappeared. These findings are clear evidence that CGRP modulates vascular tone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240–244.
Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M, Hidaka H (1987) Mechanism of action of a novel antivasospasm drug, HA 1077. J Pharmacol Exp Ther 241:1033–1040.
Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C (1985) Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 58:213–217.
Edvinsson L, Ekman R, Jansen I, Ottosson A, Uddman R (1987) Peptide-containing nerve fibers in human cerebral arteries: Immunocytochemistry, radioimmunoassay, and in vitro pharmacology. Ann Neurol 21:431–437.
Fisher LA, Kikkawa DO, Rivier JE, Amara SG, Evans RM, Rosenfeld MG, Vale WW, Brown MR (1983) Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature 305:534–536.
Franco-Cereceda A, Rudehill A, Lundberg JM (1987a) Calcitonin gene-related peptide not substance P mimics capsaicin-induced coronary vasodilation in the pig. Eur J Pharmacol 142:235–243.
Franco-Cereceda A, Gennari C, Nami R, Agnusdei D, Pernow J, Lundberg JM, Fisher JA (1987b) Cardiovascular effects of calcitonin gene-related peptides I and II in man. Circ Res 60:393–397.
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle of acetylcholine. Nature 288:373–376.
Gibbos IL, Furness JB, Costa M, MacIntyre I, Hillyard CJ, Girgis S (1985) Colocalization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. Neurosci Lett 57:125–130.
Hanko J, Hardebo JE, Kahrstrom J, Owman C, Sundler F (1985) Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibers and dilates pial and peripheral arteries. Neurosci Lett 57:91–95.
Huang M, Rorstad OP (1984) Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone. J Neurochem 43:849–856.
Kubota M, Moseley JM, Butera L, Dusting GJ, MacDonald PS, Martin TJ (1985) Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun 132:88–94.
Mason RT, Peterfreund RA, Sawchenko PE, Corrigan AZ, Rivier JE, Vale WW (1984) Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion. Nature 308:653–655.
Matsuyama T, Wakana A, Yoneda S, Kimura K, Kamada T, Girgis A, MacIntyre I, Emson PC, Toyama M (1986) Two distinct calcitonin gene-related peptide containing peripheral nervous systems: Distribution and quantitative differences between the iris and cerebral artery with special reference to substance P. Brain Res 273:205–212.
Mayberg M, Langer RS, Zervas NT, Moskowitz MA (1981) Perivascular meningeal projects from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science 213:228–230.
McCulloch J, Uddman R, Kingman TA, Edvinsson L (1986) Calcitonin gene-related peptide: functional role in cerebro-vascular regulation. Proc Natl Acad Sci [USA] 83:5731–5735.
Moskowitz MA (1984) The neurobiology of vascular head pain. Ann Neurol 16:157–163.
Moskowitz MA, Kuo C, Leeman SE, Jessen ME, Derian CK (1987) Desensitization to substance P-induced vasodilation in vitro is not shared by endogenous tachykinin neurokinin A. J Neurosci 7:2344–2351.
Poulin P, Suzuki Y, Lederis K, Rorstad OP (1986) Autoradiographic localization of binding sites for vasoactive intestinal peptide (VIP) in bovine cerebral arteries. Brain Res 381:382–384.
Rosenfeld MG, Mermod J-J, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129–135.
Saito A, Kimura S, Goto K (1986) Calcitonin gene-related peptide as potential neurotransmitter in guinea pig right atrium. Am J Physiol 250:H693-H698.
Sigrist S, Franco-Cereceda A, Muff R, Henke H, Lumdberg JM, Fisher JA (1986) Specific receptor and cardiovascular effects of calcitonin gene-related peptide. Endocrinology 119:381–389.
Suzuki Y, McMaster D, Lederis K, Rorstad OP (1984) Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries. Brain Res 322:9–16.
Suzuki Y, McMaster D, Huang M, Lederis K, Rorstad OP (1985) Characterization of functional receptors for vasoactive intestinal peptide in bovine cerebral arteries. J Neurochem 45:890–899.
Suzuki Y, Shibuya M, Ikegaki I, Satoh S, Takayasu M, Asano T (1988) Effects of neuropeptide Y on canine cerebral circulation. Eur J Pharmacol 146:271–277.
Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J (1985) Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 62:131–136.
Wakana A, Matsuyama T, Yoneda S, Kimura K, Komada T, Girgis S, MacIntyre I, Emson PC, Tohyama M (1986) Origins and distribution of calcitonin gene-related peptide-containing nerves in the wall of the cerebral arteries of the guinea pig with special reference to the coexistence with substance P. Brain Res 369:185–192.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ikegaki, I., Suzuki, Y., Satoh, Si. et al. Effects of calcitonin gene-related peptide on canine cerebral artery strips and the in-vivo vertebral blood flow in dogs. Naunyn-Schmiedeberg's Arch Pharmacol 340, 431–436 (1989). https://doi.org/10.1007/BF00167045
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00167045